Global Non-Invasive Respiratory Therapy Market Size is valued at USD 2.45 Bn in 2024 and is predicted to reach USD 4.04 Bn by the year 2034 at a 5.2% CAGR during the forecast period for 2025-2034.
Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. These treatments often treat respiratory diseases, including asthma, sleep apnea, chronic obstructive pulmonary disease, and acute respiratory distress syndrome (ARDS). Non-invasive respiratory therapy refers to treatments and approaches that are used to manage respiratory disorders without the need for intrusive procedures like intubation or surgery. Continuous technological breakthroughs have resulted in the creation of more efficient, user-friendly, and portable non-invasive respiratory equipment.
Smart inhalers, wearable gadgets, and telemedicine solutions improve the patient experience and adherence to therapy. Factors such as rising respiratory illnesses and a surge in demand for non-invasive procedures are expected to drive market expansion in the coming years. Furthermore, benefits connected with various non-invasive (NIV) ventilators are other variables related to increased device acceptance and market expansion.
However, the emergence of the COVID-19 pandemic had a substantial impact on the market under consideration. Because of the pandemic's abrupt onset, the market saw a short-term negative impact due to decreased patient visits to hospitals and clinics. However, in the later stages of the pandemic, the market experienced tremendous growth due to increasing demand for NIV for COVID-19 patients and other chronic respiratory illness patients.
The Non-Invasive Respiratory Therapy Market is segmented on the basis of product, application, and end-use. As per the product, the market is divided into Non-invasive Positive-pressure Ventilator (PPV) and non-invasive Negative Pressure Ventilator (NPV). The Positive-pressure Ventilator (PPV) segment includes Bi-level Positive Airway Pressure Ventilator (BiPAP), Constant Positive Airway Pressure Ventilator (CPAP), and Autotitrating (Adjustable) Positive Airway Pressure Ventilator (APAP). According to the application, the market consists of Asthma & Chronic Obstructive Pulmonary Disease (COPD), respiratory distress syndrome, and Others. The end-user segment includes Hospitals, Ambulatory Surgical Centers (ASCs), and Others.
The Constant Positive Airway Pressure Ventilator (CPAP) category is expected to hold a major share in the global Non-Invasive Respiratory Therapy Market in 2024. This is due to the fact that Continuous Positive Airway Pressure (CPAP) is a type of positive airway pressure used to maintain a constant pressure during both inspiration and expiration. The use of CPAP preserves PEEP, reduces atelectasis, increases alveolar surface area, improves Ventilation/Perfusion (V/Q) matching, and hence improves oxygenation. While CPAP alone is frequently insufficient for sustaining ventilation, extra pressure support during inspiration in the form of Inspiratory Positive Airway Pressure (IPAP) or Bilevel Positive Airway Pressure (BiPAP) for non-invasive ventilation is required.
The Asthma & Chronic Obstructive Pulmonary Disease (COPD) segment is projected to rapid growth in the global Non-Invasive Respiratory Therapy Market. Asthma and COPD problems are becoming more common, which has contributed to the rise in their prevalence. According to the WHO, COPD is the world's third leading reason of death, accounting for 3.23 million fatalities. Low- and middle-income countries (LMIC) account for around 90% of COPD fatalities among people under the age of 70. Tobacco use is responsible for more than 70% of COPD cases in high-income nations and 30%-40% of COPD cases in low- and middle-income countries, with household air pollution being a major risk factor. Furthermore, new product launches by prominent companies are projected to boost revenue growth in this market.
The North American non-invasive Respiratory Therapy Market is expected to record the maximum market revenue share in the near future, attributed to the increased frequency of respiratory illnesses. The market in the United States will account for the highest share in 2024, owing to technical improvements in non-invasive ventilators and the rising frequency of respiratory illnesses. According to the American Lung Association, approximately 34 million Americans are affected by chronic respiratory disorders, which include asthma and COPD, as well as emphysema and chronic bronchitis. Furthermore, new technical breakthroughs in mechanical ventilators will likely fuel this region's market revenue growth throughout the projection period. Moreover, Europe is expected to grow significantly within the forecast period. This is because of the rising incidence of respiratory illnesses and technological developments in non-invasive ventilators, as well as the country's rising prevalence of sleep apnea.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 2.45 Bn |
| Revenue Forecast In 2034 | USD 4.04 Bn |
| Growth Rate CAGR | CAGR of 5.2% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Application, Product, End-Use |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; South Korea; South East Asia |
| Competitive Landscape | ResMed Inc., Teleflex Incorporated, Hamilton Medical, Koninklijke Philips N.V., Heyer Medical AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Airon Corporation, Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare Limited, Baxter International Inc., WILAmed GmbH, Getinge AB, and others. |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Non-Invasive Respiratory Therapy Market By Product-
Non-Invasive Respiratory Therapy Market By Application-
Non-Invasive Respiratory Therapy Market By End-Use-
Non-Invasive Respiratory Therapy Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.